Atlas FDA

INTERSTIM THERAPY FOR URINARY CONTROL

FDA premarket approval P970004/S013 · decided 2001-08-17

Approval details

PMA number
P970004
Supplement
S013
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
INTERSTIM THERAPY FOR URINARY CONTROL
Generic name
Stimulator, electrical, implantable, for incontinence
Applicant
Medtronic Neuromodulation
Date received
2001-02-22
Decision date
2001-08-17
Days to decision
176 days
Decision code
APPR
Product code
EZW
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
APPROVAL FOR THE MODEL 3550-03 TWIST-LOCK SCREENING CABLE AND MODEL 3550-05 PERCUTANEOUS EXTENSION AND TUNNELING TOOL KIT FOR TEMPORARY SACRAL NERVE STIMULATION AS PART OF A STAGED IMPLANT TECHNIQUE FOR THE MEDTRONIC(R) INTERSTIM(R) THERAPY FOR URINARY CONTROL, WHICH IS INDICATED FOR THE TREATMENT OF URINARY URGE INCONTINENCE, URINARY RETENTION, AND SIGNIFICANT SYMPTOMS OF URGENCY-FREQUENCY IN PATIENTS WHO HAVE FAILED OR COULD NOT TOLERATE MORE CONSERVATIVE TREATMENTS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23